Go to Top

Blog Archives

Tag Archives: BIIB

Biogen (BIIB): Failure of the Lou Gehrig’s Disease Drug

Biogen (NASDAQ:BIIB) experimental drug for a rare disease that destroys the brain and spinal cord nerve cells failed in a company study. Biogen says it is ending its research program for the drug, dexpramipexole. The medicine was the in the late stages of testing for a treatment of amyotrophic lateral sclerosis, or ALS, which is …Read More